DFTX Operating Cash Flow Growth

Definium Therapeutics Inc · Operating Cash Flow Growth

DFTX logo

DFTX Operating Cash Flow Growth

Year-over-year change vs the same period a year earlier

Latest reported-64.30%
DFTX TTM Cash from Operations YoY % (-0.44% → -64.30%)
High-resolution chart · PNG

DFTX operating cash flow growth history

Trailing twelve months (TTM). Each value covers four complete reported quarters.

Definium Therapeutics Inc Operating Cash Flow Growth — Trailing twelve months (TTM)
Period endingOperating Cash Flow Growth
-64.3039%
-56.2676%
-64.8903%
-53.2613%
-37.6599%
-35.9564%
-22.9379%
-31.2263%
-49.5803%
-33.6495%
-28.3731%
-10.6681%
15.9403%
7.5202%
3.3763%
-13.4211%
-71.792%
-91.7631%
-119.9079%
-174.6831%
-213.4703%
-441.0445%
-4,812.5528%
-2,101.4784%
-1,006.5626%
52.5424%
31.2101%
27.4054%
-0.4369%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.